1. Home
  2. MRBK vs MDXH Comparison

MRBK vs MDXH Comparison

Compare MRBK & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$19.89

Market Cap

218.1M

Sector

Finance

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.68

Market Cap

183.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRBK
MDXH
Founded
2004
2003
Country
US
US
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
218.1M
183.4M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
MRBK
MDXH
Price
$19.89
$3.68
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$20.00
$7.67
AVG Volume (30 Days)
81.8K
111.3K
Earning Date
04-30-2026
01-01-0001
Dividend Yield
2.81%
N/A
EPS Growth
25.00
N/A
EPS
1.28
N/A
Revenue
$5,735,000.00
N/A
Revenue This Year
$25.40
$23.34
Revenue Next Year
$8.15
$22.98
P/E Ratio
$15.60
N/A
Revenue Growth
16.38
N/A
52 Week Low
$11.17
$1.35
52 Week High
$21.03
$5.33

Technical Indicators

Market Signals
Indicator
MRBK
MDXH
Relative Strength Index (RSI) 60.51 54.83
Support Level $19.76 $3.45
Resistance Level $20.66 $3.80
Average True Range (ATR) 0.59 0.20
MACD -0.05 -0.00
Stochastic Oscillator 59.41 75.00

Price Performance

Historical Comparison
MRBK
MDXH

About MRBK Meridian Corporation

Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: